Knowing the mechanism by which exosomes from drug‐resistant cells could regulate signaling pathways and mediate chemoresistance in sensitive cells, suppressing the ciRS‐122/miR‐122/PKM2 axis might be a means of reversing drug resistance in CRC. The gene discussed is PKM; the disease is colorectal carcinoma.